Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
|
A REACTION THAT OCCURS WHEN THE COMBINED EFFECT OF TWO DRIGS IS EQUAL TO THE SUM OF EACH DRUG GIVEN ALONE
|
ADDITIVE DRUG REACTION
|
|
|
UNDESIRABLE DRUG EFFECTS
|
ADVERSE REACTION
|
|
|
A DRUG THAT BINDS WITH A RECEPTOR TO PRODUCE A THERAPEUTIC RESPONSE
|
AGONIST
|
|
|
A DRUG REACTION THAT OCCURS BECAUSE THE INDIVIDUAL'S IMMUNE SYSTEM VIEWS THE DRUG AS A FOREIGN SUBSTANCE
|
ALLERGIC REACTION
|
|
|
A DRUG THAT JOINS WITH A RECEPTOR TO PREVENT THE ACTION OF AN AGONIST AT THAT RECEPTOR
|
ANTAGONIST
|
|
|
DRUGS WITH A HIGH POTENTIAL FOR ABUSE THAT ARE CONTROLLED BY SPECIAL REGULATIONS
|
CONTROLLED SUBSTANCE
|
|
|
A DRUG EFFECT THAT OCCURS WHEN THE BODY HAS NOT FULLY METABOLIZED A DOSE OF A DRUG BEFORE THE NEXT DOES IS GIVEN
|
CUMULATIVE DRUG EFFECT
|
|
|
ANY UNUSUAL OR ABNORMAL REACTION TO A DRUG
|
DRUG IDIOSYNCRASY
|
|
|
A DECREASED RESPONSE TO A DRUG, REQUIRING AN INCREASE IN DOSAGE TO ACHIEVE THE DESIRED EFFECT
|
DRUG TOLERANCE
|
|
|
THE DUSSOLUTION OF THE DRUG
|
PHARMACEUTIC PHASE
|
|
|
THE DRUG'S ACTIONS AND EFFECTS WITHIN THE BODY
|
PHARMACODYNAMICS
|
|
|
A GENETICALLY DETERMINED ABNORMALLY RESPONSE TO NORMAL DOSES
|
PHARMACOGENETIC DISORDER
|
|
|
ACTIVITIES OCCURRING WITHIN THE BODY AFTER A DRUG IS ADMINISTERED, INCLUDING ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
|
PHARMACOKINETICS
|
|
|
THE STUDY OF DRUGS AND THEIR ACTIONS ON LIVING ORGANISMS
|
PHARMACOLOGY
|
|
|
A COMPULSIVE NEED TO USE A SUBSTANCE REPEATEDLY TO AVOID MILD TO SEVERE WITHDRAWAL SYMPTOMS
|
PHYSICAL DEPENDENCE
|
|
|
A COMPULSION TO USE A SUBSTANCE TO OBTAIN A PLEASURABLE EXPERIENCE
|
PSYCHOLOGICAL DEPENDENCE
|
|
|
A SPECIALIZED MACROMOLECULE THAT BINDS TO THE DRUG MOLECULE, ALTERING THE FUNCTION OF THE CELL AND PRODUCING THE THERAPEUTIC RESPONSE
|
RECEPTOR
|
|
|
A DRUG INTERACTION THAT OCCURS WHEN DRUGS PRODUCE AN EFFECT THAT IS GREATER THAN THE SUM OF THEIR SEPARATE ACTIONS
|
SYNERGISM
|
|
|
ANY SUBSTANCE THAT CAUSES ABNORMAL DEVELOPMENT OF THE FETUS
|
TERATOGEN
|
|
|
THE INTENDED (BENEFICIAL) EFFECT OF A DRUG
|
THERAPEUTIC RESPONSE
|
|
|
HARMFUL DRUG EFFECT
|
TOXIC
|
|
|
WHAT FACTORS CAN AFFECT THE ACTIONS OF A DRUG
|
- AGE
- WEIGHT - GENDER - DISEASE - ROUTE OF ADMINISTRATION |
|
|
MEDICATION DOSAGES ARE BASED ON AN AVERAGE WEIGHT OF APPROXIMATELY WHAT
|
150 LBS
|
|
|
WHY MAY WOMEN SOMETIMES REQUIRE A SMALLER DOSE OF A MEDICATION THAN MEN
|
BECAUSE THEY GENERALLY HAVE A HIGHER PERCENTAGE OF BODY FAT AND RETAINED WATER THAN MOST MEN
|
|
|
OF ALL THE VARIOUS ROUTES OF ADMINISTRATION FOR MEDICATION, WHAT ROUTE PRODUCES THE MOST RAPID DRUG REACTION
|
INTRAVENOUS
|
|
|
WHAT DRUG ROUTE PROVIDES THE SECOND MOST RAPID REACTION
|
INTRAMUSCULAR
|
|
|
WHAT IS THE MOST FREQUENTLY USED ROUTE OF DRUG ADMINISTRATION
|
ORAL
|
|
|
A DRUG PLACED BETWEEN THE CHEEK AND EITHER THE UPPER OR LOWER JAW AND ALLOWED TO DISSOLVE IS WHAT ROUTE OF ADMINISTRATION
|
BUCCAL ROUTE
|
|
|
A DRUG PLACED OR SPRAYED UNDER THE TONGUE IS WHAT ROUTE OF ADMINISTRATION
|
SUBLINGUAL ROUTE
|
|
|
PARENTERAL DRUG ADMINISTRATION MEANS GIVING THE DRUG BY WHAT ROUTES
|
- SUBCUTANEOUS
- INTRAMUSCULAR - INTRAVENOUS - INTRADERMAL |
|
|
AN DRUG INJECTION PLACED INTO THE THE TISSUE BETWEEN THE SKIN AND MUSCLE IS WHAT ROUTE OF ADMINISTION
|
SUBCUTANEOUS
|
|
|
A DRUG INJECTION PLACED DIRECTLY INTO THE MUSCLE IS WHAT ROUTE OF ADMINISTRATION
|
INTRAMUSCULAR
|
|
|
DRUGS BEING ADMINISTERED DIRECTLY INTO THE BLOOD VIA A NEEDLE OR CATHETER INTO A VEIN IS WHAT ROUTE OF ADMINISTRATION
|
INTRAVENOUS
|
|
|
THIS ROUTE OF ADMINISTRATION IS TYPICALLY USED TO ADMINISTER SENSITIVITY TESTS, SUCH AS THE TUBERCULIN TEST
|
INTRADERMAL
|
|
|
DRUGS ADMINISTERED VIA THIS ROUTE ARE APPLIED DIRECTLY TO THE SKIN, AND ARE PRIMARILY NOT ABSORBED BY THE SKIN
|
TOPICAL
|
|
|
DRUGS ADMINISTERED VIA THIS ROUTE ARE RAPIDLY ABSORBED FROM THE SKIN AND HAVE SYSTEMIC EFFECTS.
|
TRANSDERMAL
|
|
|
DRUG DROPLETS, VAPORS AND GAS ARE ADMINISTERED THROUGH THE MUCUS MEMBRANES OF THE RESPIRATORY TRACT ARE EXAMPLES OF WHAT ROUTE OF ADMINISTRATION
|
INHALATION
|
|
|
THIS OCCURS WHEN ONE DRUG INTERACTS WITH OR INTERFERES WITH THE ACTION OF ANOTHER DRUG. FOR EXAMPLE, TAKING AN ANTACID WITH ORAL TETRACYCLINE CAUSE A DECREASE IN EFFECTIVENESS OF THE ANTIBIOTIC EFFECT OF THE TETRACYCLINE
|
A DRUG - DRUG INTERACTION
|
|
|
THIS OCCURS WHEN THE COMBINED EFFECT OF TWO DRUGS IS EQUAL TO THE SUM OF EACH DRUG GIVEN ALONE.
|
ADDITIVE DRUG REACTION
|
|
|
THIS OCCURS WHEN DRUGS INTERACT WITH ONE ANOTHER AND PRODUCE AN EFFECT THAT IS GREATER THAN THE SUM OF THEIR SEPARATE ACTIONS
|
SYNERGISTIC DRUG REACTIONS
|
|
|
THIS OCCURS WHEN ONE DRUG INTERFERES WITH THE ACTION OF ANOTHER, CAUSING NEUTRALIZATION OR A DECREASE IN THE EFFECTIVENESS OF ANOTHER DRUG
|
ANTAGONIST DRUG REACTIONS
|
|
|
WHAT TYPE OF PRESCRIPTIONS ARE NO LONGER AUTHORIZED AS PER CHAPTER 21 OF THE MANUAL OF THE MEDICAL DEPARTMENT
|
FAXED PRESCRIPTIONS
|
|
|
NON-PRESRIPTION DRUGS ARE COMMONLY REFERRED TO AS WHAT
|
OVER-THE-COUNTER (OTC)
|
|
|
WHAT FORM NUMBER IS THE "DOD PRESCRIPTION FORM"
|
DD 1289
|
|
|
WHAT FORM IS THE POLY-PRESCRIPTION
|
NAVMED 6710/6
|
|
|
CONTROLLED SUBSTANCES SHALL BE WRITTEN ONLY ON WHAT FORM
|
DD 1289
|
|
|
WHAT INFORMATION NEEDS TO BE WRITTEN ON THE PRESCRIPTION FORM IN INK, INDELIBLE PENCIL OR TYPEWRITTEN
|
- PT'S FULL NAME
- DATE WRITTEN - PT'S AGE OF DOB - FULL NAME OF DRUG, FORM, AND DOSAGE - DIRECTIONS FOR THE PT - LEGIBLE PROIVER SIGNATURE - REFILL AUTHORIZATIONS |
|
|
HOSPITAL CORPSMAN ON INDEPENDENT DUTY ARE NOT REQUIRED TO USE THE DD 1289 FOR PRESCRIBING DRUGS, OTHER THAN CONTROLLED DRUGS, UNLESS DIRECTED BY WHOM
|
THE C.O. OR HIGHER AUTHORITY
|
|
|
A KILOGRAM EQUALS HOW MANY GRAMS
|
1000
|
|
|
A GRAM EQUALS HOW MANY MILLIGRAMS
|
1000
|
|
|
A MILLIGRAM EQUALS HOW MANY MICROGRAMS
|
1000
|
|
|
IF YOU ARE CONVERTING TO A SMALLER UNIT OF MEASURE, YOU MUST MOVE THE DECIMAL IN WHAT DIRECTION
|
RIGHT
|
|
|
IF YOU ARE CONVERTING TO A LARGER UNIT OF MEASURE, YOU MUST MOVE THE DECIMAL IN WHAT DIRECTION
|
LEFT
|
|
|
THE BASIC UNIT OF WEIGHT USED FOR MEDICATION DOSING IS WHAT
|
KILOGRAM (KG)
|
|
|
A POUND CAN BE COVERTED TO KILOGRAMS HOW
|
LBS/2.2 = WEIGHT IN KG
|
|
|
A KILOGRAM CAN BE CONVERTED TO POUNDS HOW
|
KG x 2.2 LBS = WEIGHT IN LBS
|
|
|
A SOLUTION IS WHAT
|
A MIXTURE OF TWO OR MORE SUBSTANCES
|
|
|
THE SOLVENT IS WHAT PORTION OF THE SOLUTION
|
LIQUID
|
|
|
THE _____ IS THE SUBSTANCE THAT HAS BEEN DISSOLVED IN THE SOLUTION
|
SOLUTE
|
|
|
WHAT TYPE OF SOLUTION CONTAINS A GIVEN WEIGHT OF A DRUG IN A SPECIFIC WEIGHT OF SOLVENT TO ACHIEVE A FINAL SOLUTION OF 100 PARTS BY WEIGHT
|
WEIGHT IN WEIGHT
|
|
|
WHAT TYPE OF SOLUTION CONTAINS A GIVEN WEIGHT OF SOLUTE IN ENOUGH SOLVENT SO THE FINAL SOLUTION CONTAINS 100 PARTS BY VOLUME
|
WEIGHT IN VOLUME
|
|
|
WHAT TYPE OF SOLUTION CONTAINS A DEFINED VOLUME OF SOLUTE ADDED TO ENOUGH WATER SO THAT THE FINAL SOLUTION WOULD BE 100 PART BY VOLUME
|
VOLUME IN VOLUME
|
|
|
THE RATIO OF 1:10 MEANS WHAT
|
THAT 1 PART VOLUME OR WEIGHT IS MIXED TO MAKE A FINAL SOLUTION OF 10 PARTS BY VOLUME
|
|
|
A RATIO OF 1:1:1 MEANS WHAT
|
EQUAL PARTS OF EACH INGREDIENT CONTAINED IN THE PRODUCT
|
|
|
A RATIO OF 1:1,000 MEANS WHAT
|
THAT THERE IS 1 GRAM OF DRUG PER 1,000 PARTS OF SOLUTION
|
|
|
REQUIRES OXYGEN TO SURVIVE
|
AEROBIC
|
|
|
ABLE TO LIVE WITHOUT OXYGEN
|
ANAEROBIC
|
|
|
ACTIVE AGAINST BACTERIA
|
ANTIBACTERIAL
|
|
|
ABILITY OF BACTERIA TO PRODUCE SUBSTANCES THAT INACTIVATE OR DESTROY THE IMPACT OF THE DRUG
|
BACTERIAL RESISTANCE
|
|
|
THE AGENT OR DRUG THAT DESTROYS BACTERIA
|
BACTERICIDAL
|
|
|
DRUGS THAT SLOW OR RETARD THE MULTIPLICATION OF BACTERIA
|
BACTERIOSTATIC
|
|
|
DRUGS EFFECTIVE AGAINST BOTH GRAM NEGATIVE ( - ), AND GRAM POSITIVE ( + ) BACTERIA
|
BROAD SPECTRUM
|
|
|
ALLERFY TO DRUGS IN THE SAME OR RELATED GROUP
|
CROSS SENSITIVITY
|
|
|
NONPATHOGENIC MICROORGANISMS WITHIN OR ON THE BODY
|
NORMAL FLORA
|
|
|
AN OVERGROWTH OF BACTERIA OR FUNGAL MICROORGANISMS NOT AFFECTED BY THE ANTIBIOTIC BEING USED FOR TX
|
SUPERINFECTION
|
|
|
UNLIKE PREVIOUS TREATMENTS FOR INFECTIONS, WHICH INCLUDED POISONS SUCH AS STRYCHNINE AND ARSENIC, ANTIBIOTICS WERE LABELED AS WHAT
|
"MAGIC BULLETS" DRUGS WHICH TARGETED DISEASE WITHOUT HARMING THE HOST
|
|
|
ANTIBIOTICS ARE NOT EFFECTIVE IN WHAT TYPE OF INFECTIONS
|
VIRAL, FUNGAL OR OTHER NONBACTERIAL
|
|
|
THE EFFECTIVENESS OF INDIVIDUAL ANTIBIOTICS DEPENDS ON WHAT FACTORS
|
- LOCATION OF THE INFECTION
- ABILITY OF THE ABX TO REACH THE SITE OF INFECTION - ABILITY OF THE BACTERIA TO RESIST OR INACTIVATE THE ABX |
|
|
____ ANTIBIOTICS ARE THE SIMPLEST APPROACH WHEN EFFECTIVE
|
ORAL
|
|
|
LIST THE VARIOUS CLASSES OF ANTIBIOTICS
|
- AMINOGLYCOSIDES
- CARBAPENEMS - 1ST GEN CEPHALOSPORINS - 2ND GEN CEPHALOSPORINS - 3RD GEN CEPHALOSPORINS - EXTENDED SPECTRUM PCN'S - FLUROQUINOLONES - MACROLIDES - PCN'S - TETRACYCLINES - MISC... |
|
|
WHAT MEDICATIONS ARE USED IN THE MANAGEMENT OF HERPES VIRUS INFECTIONS
|
- ACYCLOVIR
- FAMCICLOVIR - VALACYCLOVIR |
|
|
IN ADDITION TO THE TREATMENT OF HERPES, ACYCLOVIR IS ALSO USED IN THE TREATMENT OF WHAT
|
CHICKENPOX
|
|
|
WHAT MEDICATIONS ARE USED PRIMARILY IN THE PREVENTION OF INFLUENZA A VIRAL INFECTIONS
|
OSELTAMIVIR AND ZANAMIVIR
|
|
|
WHAT MEDICATIONS ARE USED IN THE TREATMENT OF CYTOMEGALOVIRUS (CMV) RETINITIS
|
- CIDOFOVIR
- GANCICLOVIR - VALGANCICLOVIR - FOSCARNET |
|
|
WHAT MEDICATION IS USED ONLY TO TREAT OPTHALMIC VIRAL INFECTIONS
|
VIDARABINE
|
|
|
WHAT MEDICATIONS ARE USED IN THE TREATMENT AND PREVENTION OF ORAL-FACIAL HERPES SIMPLEX
|
PENCICLOVIR AND DOCOSANOL
|
|
|
WHAT ARE THE CONTRAINDICATIONS FOR THE USE OF ANTIVIRALS
|
PREVIOUS HYPERSENSITIVITY
|
|
|
ALL TYPES OF ANTIVIRALS EXCEPT WHAT REQUIRE DOSE ADJUSTMENT IN RENAL IMPAIRMENT
|
ZANAMIVIR
|
|
|
ACYCLOVIR MAY CAUSE WHAT WHEN USED
|
RENAL IMPAIRMENT AND CNS TOXICITY
|
|
|
WHAT ANTIVIRAL INCREASES THE RISK OF SEIZURES
|
FOSCARNET
|
